TGFB1 and hepatocellular carcinoma: TGF-β1 and IL-6 are predominantly produced by TAMs in hepatocellular carcinoma (HCC), which induce EMT and activate the STAT3 pathway, respectively, to promote liver CSC properties [50, 51].